Vir Biotechnology
VIR
VIR
212 hedge funds and large institutions have $611M invested in Vir Biotechnology in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 80 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0% less funds holding
Funds holding: 213 → 212 (-1)
3.15% less ownership
Funds ownership: 80.18% → 77.03% (-3.1%)
24% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 80
Holders
212
Holding in Top 10
3
Calls
$1.44M
Puts
$742K
Top Buyers
| 1 | +$6.03M | |
| 2 | +$4.49M | |
| 3 | +$2.97M | |
| 4 |
Two Sigma Investments
New York
|
+$1.6M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.5M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$3.99M | |
| 3 | -$2.71M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.44M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$2.16M |
